Print Version
Frequently Asked Questions About the 4-Drug Fixed-dose Combination Tablet Recommended by the World Health Organization for Treating Tuberculosis
Author:
Stop TB Partnership
Publication Date:
2002
Format:
Booklet
Language:
English
Abstract
This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB.Publisher:
Stop TB Partnership
Audience(s):
International Agencies
Topic:
TB Treatment, Treatment- Medication Information
Notes:
The document may be freely reviewed, reproduced, or translated in part or in full, but not for sale or for use in conjunction with commercial purposes.
Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.